About Us Strategy & Mission Our Values Our People Our Board Our Scientific Advisors Our Collaborations Contact Our Programs Pipeline C. difficile Infection Enterobacteriaceae Clinical Trials Our Science Discuva Platform Scientific Literature & Publications Investors Investor Center Press Releases Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
SMT026571 : The Development of a Novel Oral Antibiotic to Treat Multi-Drug Resistant Neisseria gonorrhoeae SMT026571 : The Development of a Novel Oral Antibiotic to Treat Multi-Drug Resistant Neisseria gonorrhoeae September 5, 2018 By CKD Digital
SMT026571 : The Development of a Novel Oral Antibiotic to Treat Multi-Drug Resistant Neisseria gonorrhoeae
SMT026571 : The Development of a Novel Oral Antibiotic to Treat Multi-Drug Resistant Neisseria gonorrhoeae September 5, 2018 By CKD Digital
